The reported
in-vitro antimicrobial spectrum of the principle active ingredient
of Prometics formulations (prior
to synergistic enhancement) is shown below:
Bacteria |
Fungi |
Virusses |
| Mycobacterium TB hominis |
Trichophyton interdigitale |
Herpes simplex 1 |
| Tubercle bacilli |
Trichophyton purpureum |
Herpes simplex 2 |
| Streptococcus fecalis |
Trichophyton violaceum |
Influenza |
| Streptococcus mutans |
Microsprum audouini |
Semliki Forest virus |
| Streptococcus agalactiae |
Epidermophyton inguinale |
|
| Streptococcus Group A |
Torula sp. |
|
| Streptococcus ß-hemolytic |
Saccharomyces cerevisiae |
|
| Bacillus metiens |
Candida albicans |
|
| Serratia marcescens |
Monilia albicans |
|
| Clostridium botulium spores |
Aspergillus niger |
|
| Helicobacter pylori |
Penicillium notatum |
|
| Staphylococcus
aureus |
Neurospora crassa |
|
| MRSA |
|
|
| Escheria coli |
|
|
| Pseudomonas aeruginosa |
|
|
| Enterococci |
|
|
| VRE |
|
|
| Pneumococci |
|
|
| |
|
|
The
synergistically interacting ingredients of Prometics
XL formulation further expand the above lists
to include various strains of MRSA, Group D Streptococci,
Clostridium dificile, and the Sterne strain of Anthrax,
amongst others.
————————————————————————————————————
Prometics Bodycare Limited®. All
rights reserved.
